WEREWOLF THERAPEUTICS INC. - COMMON STOCK
1.2300
12-3月-25 15:45:01
15 分の遅延
株式
-0.0300
-2.38%
本日の幅
1.2200 - 1.2963
ISIN
N/A
ソース
NASDAQ
-
Werewolf Therapeutics Appoints Meeta Chatterjee, Ph.D., to its Board of Directors
28 10 2021 15:01:00 提供 Nasdaq GlobeNewswire
-
27 10 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at Upcoming Next-Gen Cytokine Therapeutics Summit
14 9 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at H. C. Wainwright Global Investment Conference
08 9 2021 07:00:03 提供 Nasdaq GlobeNewswire
-
18 8 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
Werewolf Therapeutics Reports Second Quarter 2021 Financial Results and Business Update
12 8 2021 06:00:01 提供 Nasdaq GlobeNewswire
-
Werewolf Therapeutics Announces Its Addition to the Russell 2000® Index
24 6 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
Werewolf Therapeutics Appoints Chulani Karunatilake, Ph.D. as Chief Technology Officer
15 6 2021 06:00:01 提供 Nasdaq GlobeNewswire
-
Werewolf Therapeutics Reports First Quarter 2021 Financial Results
10 6 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
Werewolf Therapeutics Appoints Mike Sherman to its Board of Directors
28 5 2021 06:00:00 提供 Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at Jefferies Virtual Healthcare Conference 2021
27 5 2021 06:30:00 提供 Nasdaq GlobeNewswire